EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Akari Therapeutics, Plc and Reminds Investors with Losses In Excess of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / June 26, 2017 / Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against Akari Therapeutics, Plc ("Akari" or the "Company") (AKTX) regarding possible violations of federal securities laws from March 30, 2017 through May 11, 2017, inclusive (the "Class Period"). Investors, who purchased or otherwise acquired shares during the Class Period, should contact the firm prior to the July 11, 2017 lead plaintiff motion deadline.

To participate in this class action lawsuit, click here.

You can also call Brian Lundin, Esq., of Lundin Law PC, at 888-713-1033, or you can e-mail him at brian@lundinlawpc.com.

No class has been certified in the above action yet. Until a class is certified, you are not considered represented by an attorney. You may choose to do nothing and be an absent class member as well.

According to the Complaint, throughout the Class Period, Akari made materially false and/or misleading statements, and/or failed to disclose materially adverse facts about its business, operations, and prospects. On April 26, 2017, Edison Research Ltd. issued a report on the Company called "Akari's Coversin matches Soliris in Phase II." The next day, it was announced that the report was withdrawn due to "material inaccuracies." On May 11, 2017, Akari announced that Chief Executive Officer, Dr. Gur Roshwalb, has been placed on administrative leave while the Board of Directors reviews whether Dr. Roshwalb and other executives were involved with the materially inaccurate research report. Upon the release of this information, Akari shares fell in value, which harmed investors according to the Complaint.

Lundin Law PC was founded by Brian Lundin, Esq., a securities litigator based in Los Angeles dedicated to upholding shareholders' rights.

This press release may constitute Attorney Advertising in certain jurisdictions under the applicable law and ethics rules.

Contact:

Lundin Law PC
Brian Lundin, Esq.
Telephone: 888-713-1033
Facsimile: 888-713-1125
brian@lundinlawpc.com
http://lundinlawpc.com/

SOURCE: Lundin Law PC

Advertisement